KSCMS @ GW-ICC Joint Forum – Great Wall International Congress of Cardiology (GW-ICC) 2017 – How to Use Statins to Maximize Cardiometabolic Benefits

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses. Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies to introduce important Chinese academic research.

At the 28th GW-ICC in 2017, the Korean Society of Cardio metabolic Syndrome (KSCMS) held a Joint Forum. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

How to Use Statins to Maximize Cardiometabolic Benefits

Presenter: Kwang Kon Koh, MD, PhD, FACC, Gachon University of Korea, Incheon, South Korea.

Dr Kon Koh discusses statin guidelines to maximise cardiometabolic benefits:

Primary prevention

  • Without risk factors for diabetes: low (for Asian) or optimal (for Caucasian) dose statins alone.
  • Without risk factors for diabetes: low or optimal dose statins +/- ezetimbe combined with RAAS blockades or PPARa agonists to reduce diabetogenic effects of statins.

Secondary prevention

  • In acute coronary syndrome state: potent high dose statins +/- ezetimbe/PCSK9 inhibitors/inclisiran because cardiovascular benefits of statins exceed diabetogenic or other risks.
  • In stable coronary artery diseases: optimal dose statins +/- ezetimbe combined with RAAS blockades or PPARa

Further information on the 29th GW-ICC, to be held October 11th -14th, 2018, in Beijing, China, is available on the congress website:


Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://cvia-journal.org/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

Updated: November 26, 2020 — 12:36 pm